Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_assertion type Assertion NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_head.
- NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_assertion description "[However, the ubiquity, extent, and correlation with disease progression suggest that aberrant DNA methylation is the dominant mechanism for TSG silencing and clonal variation in MDS evolution to AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_provenance.
- NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_assertion evidence source_evidence_literature NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_provenance.
- NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_assertion SIO_000772 18832655 NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_provenance.
- NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_assertion wasDerivedFrom befree-20140225 NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_provenance.
- NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_assertion wasGeneratedBy ECO_0000203 NP817744.RAWlXBD1ds07IK7qCNthS9nwDchSx8tOr-imFMKCw-Yfs130_provenance.